Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "junction proteins" is overly broad: it refers collectively to several families of proteins responsible for forming the physical connections between adjacent cells in tissues, rather than a single molecular entity. The main classes include tight junction proteins, adherens junction proteins, desmosomal proteins, gap junction proteins, and hemidesmosomal proteins. Each class contains multiple specific transmembrane and scaffold proteins, with diverse biological and disease roles. Junction proteins collectively refer to the multiple families of proteins that mediate cell-cell and cell-matrix adhesion in multicellular organisms. These include tight junction proteins (e.g., claudins, occludin, junctional adhesion molecules), adherens junction proteins (e.g., cadherins, catenins), desmosomal proteins (e.g., desmogleins, desmocollins), gap junction proteins (connexins), and hemidesmosomal proteins (integrins). Each class forms distinct structural complexes with unique roles: - Tight junction proteins seal epithelial and endothelial sheets and regulate paracellular permeability. - Adherens junction and desmosomal proteins provide structural cohesion and mechanical stability. - Gap junction proteins (connexins) enable intercellular communication by forming channels for ions and small molecules. - Hemidesmosomal proteins anchor cells to the extracellular matrix. These proteins participate in critical processes including maintenance of tissue architecture, signal transduction, regulation of growth and differentiation, and response to physiological stress. Disruption or dysfunction of these proteins is implicated in cancer, inflammation, degenerative diseases, and infection. However, as a broad group, "junction proteins" is not a single defined therapeutic target; individual members within these groups, such as claudin-1, occludin, JAM-A, or connexin43, may serve as specific targets or biomarkers in disease contexts. Summary: "Junction proteins" is not a singular molecular target but a functional and structural group encompassing many protein families responsible for intercellular and cell-matrix adhesion. More specific information can only be provided by specifying an individual protein (e.g., "Claudin-1" or "Connexin 43").
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Junction Proteins.